Combination of sitaxentan and tadalafil for idiopathic pulmonary arterial hypertension following relapse on bosentan
(2009)
Journal Article
Faruqi, S., Fathi, H., & Morice, A. H. (2010). Combination of sitaxentan and tadalafil for idiopathic pulmonary arterial hypertension following relapse on bosentan. International journal of cardiology, 144(3), e43-e45. https://doi.org/10.1016/j.ijcard.2008.12.065
Sitaxentan, a highly-selective endothelin receptor antagonist (ETRA) and bosentan a non-selective ETRA are both approved for the treatment of idiopathic pulmonary arterial hypertension (iPAH). Sildenafil is a phosphodiesterase-5 (PDE-5) inhibitor use... Read More about Combination of sitaxentan and tadalafil for idiopathic pulmonary arterial hypertension following relapse on bosentan.